Restart Life Sciences Corp.
NMLSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $659 | $2,533 | $13,407 | $5,983 |
| - Cash | $11 | $8 | $267 | $219 |
| + Debt | $80 | $0 | $0 | $0 |
| Enterprise Value | $728 | $2,525 | $13,141 | $5,764 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $25 | -$4 | -$5 |
| % Margin | – | – | – | – |
| EBITDA | -$656 | -$1,202 | -$1,842 | -$2,798 |
| % Margin | – | – | – | – |
| Net Income | $225 | -$1,224 | -$2,466 | -$2,685 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.014 | -0.083 | -0.18 | -0.24 |
| % Growth | 117.3% | 53.8% | 25% | – |
| Operating Cash Flow | -$72 | -$278 | -$1,444 | -$1,946 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$72 | -$278 | -$1,444 | -$1,946 |